9.47
                                            Schlusskurs vom Vortag:
              $9.80
            Offen:
              $9.94
            24-Stunden-Volumen:
                168.36K
            Relative Volume:
              1.32
            Marktkapitalisierung:
                $308.98M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              -7.07%
            1M Leistung:
              +6.88%
            6M Leistung:
                -24.12%
            1J Leistung:
              +0.00%
            Jade Biosciences Inc Stock (JBIO) Company Profile
Firmenname
                  
                      Jade Biosciences Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      617-443-2400
                    
                Adresse
                  
                      930 WINTER STREET, WALTHAM
                    
                Vergleichen Sie JBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                JBIO
                            
                             
                        Jade Biosciences Inc 
                           | 
                    9.47 | 450.75M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-09 | Eingeleitet | BTIG Research | Buy | 
| 2025-07-14 | Eingeleitet | Jefferies | Buy | 
| 2025-06-16 | Hochstufung | Guggenheim | Neutral → Buy | 
| 2025-05-07 | Eingeleitet | Wedbush | Outperform | 
| 2025-05-05 | Eingeleitet | Stifel | Buy | 
| 2025-05-02 | Eingeleitet | TD Cowen | Buy | 
| 2024-06-18 | Herabstufung | Evercore ISI | Outperform → In-line | 
| 2024-06-18 | Herabstufung | TD Cowen | Buy → Hold | 
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight | 
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral | 
| 2024-06-17 | Herabstufung | Guggenheim | Buy → Neutral | 
| 2024-06-17 | Herabstufung | Wedbush | Outperform → Neutral | 
| 2024-03-25 | Fortgesetzt | Jefferies | Buy | 
| 2023-12-08 | Eingeleitet | Wells Fargo | Equal Weight | 
| 2023-03-01 | Eingeleitet | Guggenheim | Buy | 
| 2022-12-06 | Hochstufung | BTIG Research | Neutral → Buy | 
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform | 
| 2022-08-16 | Herabstufung | BTIG Research | Buy → Neutral | 
| 2022-02-11 | Eingeleitet | BTIG Research | Buy | 
| 2021-07-26 | Eingeleitet | Cowen | Outperform | 
| 2021-07-26 | Eingeleitet | Evercore ISI | Outperform | 
| 2021-07-26 | Eingeleitet | Jefferies | Buy | 
| 2021-07-26 | Eingeleitet | Wedbush | Outperform | 
                    Alle ansehen
                    
                  
                Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten
How Jade Biosciences Inc. stock reacts to Fed rate cutsBull Run & Weekly High Potential Stock Alerts - newser.com
Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance
Will Jade Biosciences Inc. see short term momentumMarket Growth Review & Low Risk Entry Point Tips - newser.com
Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Jade Biosciences (NASDAQ:JBIO) Receives "Sell (E)" Rating from Weiss Ratings - MarketBeat
How Jade Biosciences Inc. stock reacts to inflationary pressures2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
How Jade Biosciences Inc. stock performs during Fed tightening cyclesWeekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com
Is Jade Biosciences Inc. stock positioned for long term growthQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Will Jade Biosciences Inc. stock see PE expansionWeekly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Is Jade Biosciences Inc. forming a reversal pattern2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Jade Biosciences Advances with Phase 1 Study of JADE101 - TipRanks
Jade Biosciences (JBIO) Price Target Increased by 13.43% to 19.38 - Nasdaq
Will Jade Biosciences Inc. stock keep outperforming rivals2025 Key Lessons & Real-Time Chart Pattern Alerts - fcp.pa.gov.br
Multi asset correlation models including Jade Biosciences Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - newser.com
What technical charts say about Jade Biosciences Inc. stockJuly 2025 Analyst Calls & Weekly High Conviction Ideas - fcp.pa.gov.br
Aug Summary: Will Jade Biosciences Inc. stock benefit from automationQuarterly Performance Summary & Community Driven Trade Alerts - fcp.pa.gov.br
Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)
        Es liegen keine Finanzdaten für Jade Biosciences Inc (JBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):